Join to View Full Profile
3401 N Broad StPhiladelphia, PA 19140
Phone+1 215-707-3040
Fax+1 215-707-8235
Dr. Kala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Narendra Kala, based in Philadelphia, PA specializes in neurology with a subspeciality in vascular neurology. Dr. Kala has contributed extensively to his field, with a number of publications in renowned journals including Stroke, Echocardiography, Neurology. His clinical pursuit and research focuses on anti-thrombotics, dissections, cerebral venous thrombosis and intracranial atherosclerosis.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Vascular Neurology, 2020 - 2021
Geisinger Health System (Danville)Residency, Neurology, 2016 - 2020
Maharajah’s Institute of Medical SciencesClass of 2015, MBBS
Certifications & Licensure
PA State Medical License 2020 - 2026
RI State Medical License 2020 - 2024
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Vascular Neurology
Publications & Presentations
PubMed
- Factors Associated With Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection.Daniel M Mandel, Liqi Shu, Christopher Chang, Naomi Jack, Christopher R Leon Guerrero
Stroke. 2025-03-27 - Left Ventricular Diastolic Dysfunction with Elevated Filling Pressures Is Associated with Embolic Stroke of Undetermined Source and Atrial Fibrillation.Zubair Bashir, Liqi Shu, Yuqian Guo, Edward W Chen, Shuyuan Wang
Tomography. 2024-10-14 - Intravenous Thrombolysis in Patients With Cervical Artery Dissection: A Secondary Analysis of the STOP-CAD Study.Liqi Shu, Favour Akpokiere, Daniel M Mandel, Thalia S Field, Christopher R Leon Guerrero
Neurology. 2024-10-08
Press Mentions
Targeted, Anti-Clotting Meds Had Less Risk of Major Bleeding for Rare, Deadly StrokesFebruary 10th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
